Costs Associated With the Management and Morbidity of Diabetic Macular Oedema and Macular Oedema Secondary to Retinal Vein Occlusion

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.09.542
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Intravitreal Bevacizumab for the Treatment of Macular Oedema Secondary to Branch Retinal Vein Occlusion

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2008English

Intravitreal Bevacizumab for Macular Oedema Secondary to Branch Retinal Vein Occlusion: More Data Required

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2009English

Relationship Between Perifoveal Capillaries and Pathomorphology in Macular Oedema Associated With Branch Retinal Vein Occlusion

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2012English

Intravitreal Triamcinolone Acetonide vs Bevacizumab for Treatment of Macular Oedema Secondary to Branch Retinal Vein Occlusion

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2009English

Macular Cystic Changes as Predictive Factor for the Recurrence of Macular Oedema in Branch Retinal Vein Occlusion

Acta Ophthalmologica
MedicineOphthalmology
2017English

Fingolimod-Associated Macular Oedema

BMJ Case Reports
Medicine
2017English

Initial Treatment of Macular Oedema Due to Central Retinal Vein Occlusion—which Anti-Vegf Agent to Choose?

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2019English

A Meta-Analysis of Patients With Treatment-Resistant Macular Oedema Secondary to Retinal Vein Occlusions Following Switching to Aflibercept

Acta Ophthalmologica
MedicineOphthalmology
2018English

One-Year Treatment Outcomes of Ziv-Aflibercept for Treatment-Naïve Macular Oedema in Branch Retinal Vein Occlusion

Acta Ophthalmologica
MedicineOphthalmology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy